Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial)

Chen, Liang; Gao, Ming-Xin; Du, Xin; Wang, Chi; Yu, Wen-Yuan; Liu, Hong-Li; Ding, Xiao-Hang; Wang, Bo-Lin; Zhang, Kui; Xu, Dong; Han, Zhen; Xie, Bao-Dong; Dong, Ran; Yu, Yang

doi:10.1186/s13063-023-07737-8

Trials

Article metrics
Last updated: Sat, 18 May 2024 5:38:01 Z

Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial)

Access & Citations

744

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com